Is BMY or GSK cheaper?

On trailing earnings, GSK is cheaper: BMY trades at a 15.56 P/E and GSK at 11.62.

Which has grown faster, BMY or GSK?

Over the past five years, BMY grew revenue faster — BMY at a 2.52% CAGR versus GSK at 0.63%.

Does BMY or GSK pay a bigger dividend?

BMY yields 4.55% and GSK yields 3.51% based on trailing dividends and the latest price.

Is BMY or GSK more profitable?

GSK runs the higher net margin — BMY at 15.01% versus GSK at 17.76%.

Which has been the better investment, BMY or GSK?

Over the past 10-year, GSK delivered the higher annualized total return — BMY at 1.33% versus GSK at 7.50%. Past performance doesn't predict future results.

Bristol-Myers Squibb Company (BMY) vs GSK plc (GSK)

GSK leads on 10 of 16 compared metrics.

A side-by-side comparison of Bristol-Myers Squibb Company and GSK plc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 26, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

BMY

Bristol-Myers Squibb Company

Total return — BMY vs GSK

growth of $100 · last 30y

BMY +168.7%GSK +98.1%BMY compounded faster

BMY GSK

BMY vs GSK: by the numbers

•BMY is the larger company ($116.46B vs $105.20B market cap).
•GSK trades at the lower earnings multiple (11.62 vs 15.56 P/E).
•GSK converts more revenue to profit (17.76% vs 15.01% net margin).
•BMY grew revenue faster over the past five years (2.52% vs 0.63% CAGR).
•BMY pays the higher dividend yield (4.55% vs 3.51%).

Which is better, BMY or GSK?

Metric tally: BMY 6 · GSK 10

It depends on what you're optimizing for:

ValueGSK(lower P/E)

GrowthBMY(faster 5Y revenue CAGR)

IncomeBMY(higher dividend yield)

QualityGSK(higher ROIC)

Metrics side by side

Valuation

Metric	BMY	GSK
P/E ratio	15.56	11.62●
Forward P/E	9.03●	13.25
P/S ratio	2.33●	2.42
P/B ratio	5.64	3.44●
PEG ratio	1.66	0.02●
EV / EBITDA	9.41	8.62●
FCF yield	10.52%●	7.87%

Profitability

Metric	BMY	GSK
Gross margin	68.75%	72.67%●
Operating margin	25.67%	25.65%
Net margin	15.01%	17.76%●
ROE	36.25%●	25.19%
ROIC	13.90%	16.61%●

Dividends

Metric	BMY	GSK
Dividend yield	4.55%●	3.51%
Payout ratio	72.83%	24.30%

Growth (annualized)

Metric	BMY	GSK
Revenue CAGR (5Y)	2.52%●	0.63%
EPS CAGR (5Y)	9.38%	14.05%●
FCF CAGR (5Y)	-2.50%	-0.35%●
Total return CAGR (5Y)	0.85%	10.18%●

Frequently asked

Which is better, BMY or GSK?: It depends on your goal. value: GSK (lower P/E); growth: BMY (faster 5Y revenue CAGR); income: BMY (higher dividend yield); quality: GSK (higher ROIC). Across all compared metrics, GSK leads 10 to 6.
Is BMY or GSK cheaper?: On trailing earnings, GSK is cheaper: BMY trades at a 15.56 P/E and GSK at 11.62.
Which has grown faster, BMY or GSK?: Over the past five years, BMY grew revenue faster — BMY at a 2.52% CAGR versus GSK at 0.63%.
Does BMY or GSK pay a bigger dividend?: BMY yields 4.55% and GSK yields 3.51% based on trailing dividends and the latest price.
Is BMY or GSK more profitable?: GSK runs the higher net margin — BMY at 15.01% versus GSK at 17.76%.
Which has been the better investment, BMY or GSK?: Over the past 10-year, GSK delivered the higher annualized total return — BMY at 1.33% versus GSK at 7.50%. Past performance doesn't predict future results.

Go deeper

Full BMY analysis Full GSK analysis Interactive comparison tool

Dig into the metrics

Bristol-Myers Squibb P/E ratio GSK P/E ratio Bristol-Myers Squibb dividend yield GSK dividend yield Bristol-Myers Squibb ROE GSK ROE Bristol-Myers Squibb operating margin GSK operating margin Bristol-Myers Squibb revenue growth GSK revenue growth Bristol-Myers Squibb free cash flow GSK free cash flow

Bristol-Myers Squibb & GSK appear in these rankings

Highest Dividend Yield Stocks Highest ROE Stocks Highest FCF Yield Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 26, 2026.